News

California Team Awarded $3 Million Federal Grant to Uncover Impact of Pandemic on PreK-12 Students

Researchers will study how California’s $4.6 billion pandemic recovery grant program, known as the Expanded Learning Opportunities (ELO) Grant, was used to promote educational recovery from COVID-19 and to address worsening learning gaps and inequities […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

University of Arkansas Contracts Dalrada Corporation’s Deposition Technology Ltd. to Build a Plasma Enhanced Chemical Vapor Deposition Tool

SAN DIEGO–(BUSINESS WIRE)–Dalrada Corporation’s Deposition Technology Ltd. semiconductor machine brings research and high-volume manufacturing to the University of Arkansas. Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Senhwa Announces First Patient Successfully Dosed in Phase I Study of Pindnarulex in Combination with Pfizer’s Talazoparib for the Treatment of Prostate Cancer

TAIPEI and SAN DIEGO, Oct. 31, 2022 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, announced today that their first patient […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
News

Two Aurinia execs are out — and CRISPR’s operations chief isn’t far behind; Biogen MS leader jumps to Eli Lilly partner

Robert Huizinga ? According to an SEC filing, Aurinia’s EVP of research Robert Huizinga and CMO Neil Solomons are both walking away by Halloween, and while no explanations are given, details of their severance packages […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

International Lennox-Gastaut Syndrome (LGS) Awareness Day, November 1st, to Kick Off Epilepsy Awareness Month

SAN DIEGO, Oct. 27, 2022 /PRNewswire/ — On November 1st, the Lennox-Gastaut Syndrome (LGS) Foundation will join families, researchers, clinicians, and advocates worldwide to observe International LGS Awareness Day. On this day, thousands of individuals […]

No Picture
News

Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating NBI-1117568 in Adults with Schizophrenia

NBI-1117568 is an Investigational, First-in-Class, Muscarinic M4 Selective Agonist SAN DIEGO, Oct. 27, 2022 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, today announced the first patient has been randomized for […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Cali Biosciences Announces Publications of Phase IIa Results of Long-Acting Ropivacaine (CPL-01)

CPL-01, for Non-Opioid Treatment of Post-Operative Pain, Garners Publication of Clinical Data in Abdominoplasty and Presentation of Preclinical Data in Bony and Soft-Tissue Models Supporting Pharmacokinetics and Safety SAN DIEGO, Oct. 26, 2022 /PRNewswire/ — […]